article thumbnail

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Express Pharma

The nutraceutical market began to gain traction around 2005-2010, growing steadily since then. billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3 People are increasingly leaning towards prevention and preventive care rather than relying solely on therapeutic medications. per cent from 2024 to 2030.

Diabetes 105
article thumbnail

Mass spectrometry software can link different data types

European Pharmaceutical Review

Integrative workflows combining IMS data from LC-MS and MS imaging enable large-scale metabolomics and lipidomics research by spectral preprocessing, feature detection and various options for compound identification for thousands of samples in parallel. The latest advances in the MZmine 3 have been published in Nature Biotechnology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca launches call for entries to the 2023 global R&D Postdoctoral Challenge

LifeProNow

Working alongside a leading university, researchers will also receive access to in-house expertise, compounds, novel tools and technologies and mentoring support to develop their ideas and innovate.

article thumbnail

AstraZeneca launches call for entries to 2023 global R&D Postdoctoral Challenge

LifeProNow

Working alongside a leading university, researchers will also receive access to in-house expertise, compounds, novel tools and technologies and mentoring support to develop their ideas and innovate.

article thumbnail

Revolutionising outcomes: Agile CROs lead the way

Express Pharma

CROs: The torchbearers To strike a balance between quality and cost, global pharmaceutical giants have, since 2005, leaned towards Indian clinical research organisations (CROs), especially for generics. Given the current trajectory, the figures could balloon to $68.9 billion by 2025 and approach $84.44 billion by 2030.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. Following his graduate studies, Dr Hoppin was an Alexander von Humboldt Fellow at the Research Center Jülich, Center for Electronics in Germany from 2003 to 2005.

article thumbnail

Safe Handling of Hazardous Drugs

RX Note

Workplace activity involves how healthcare workers use and handle the drug in the workplace - such as opening shipments, compounding, administering or cleaning up after use or spills. Oral hazardous drugs No crushing or compounding may be done in an unprotected environment. Consider having spill-response exercises or drills.